Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma

Abstract

Taken together, these results indicate that elevated levels of KLK6 in GBM are likely to promote the resistance of tumor cells to cytotoxic agents and are an indicator of reduced patient postsurgical survival times.